0001062993-22-002726.txt : 20220204 0001062993-22-002726.hdr.sgml : 20220204 20220204192638 ACCESSION NUMBER: 0001062993-22-002726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zarur Juan Andrey CENTRAL INDEX KEY: 0001727404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39894 FILM NUMBER: 22595166 MAIL ADDRESS: STREET 1: C/O SOLID BIOSCIENCES, LLC STREET 2: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC CENTRAL INDEX KEY: 0001822691 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851914700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 BUSINESS PHONE: (617) 616-8188 MAIL ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 FORMER COMPANY: FORMER CONFORMED NAME: Environmental Impact Acquisition Corp DATE OF NAME CHANGE: 20200826 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-02-02 0001822691 GreenLight Biosciences Holdings, PBC GRNA 0001727404 Zarur Juan Andrey C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 1 1 0 0 President & CEO Common Stock 2022-02-02 4 A 0 896058 A 896058 D Stock Option (Right to Buy) 0.35 2022-02-02 4 A 0 70319 A 2023-07-29 Common Stock 70319 70319 D Stock Option (Right to Buy) 0.33 2022-02-02 4 A 0 926330 A 2028-09-13 Common Stock 926330 926330 D Stock Option (Right to Buy) 0.50 2022-02-02 4 A 0 1982609 A 2029-12-29 Common Stock 1982609 1982609 D Stock Option (Right to Buy) 0.50 2022-02-02 4 A 0 668830 A 2029-12-29 Common Stock 668830 668830 D Stock Option (Right to Buy) 0.98 2022-02-02 4 A 0 1906944 A 2030-12-01 Common Stock 1906944 1906944 D Stock Option (Right to Buy) 0.98 2022-02-02 4 A 0 292649 A 2030-12-01 Common Stock 292649 292649 D Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company. 100% of the shares subject to this option are fully vested and exercisable. This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company. 20% of the shares underlying the option vested or shall vest on September 12, 2018 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018. 20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021. 20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021. 25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022. 25% of the shares underlying the option vested or shall vest after one year of service and the remainder of the shares vested or shall vest in 36 equal monthly installments. /s/ David Kennedy, Attorney-in-fact 2022-02-04